(G116) Validation of a New Exosome-Based RT-qPCR Test to Monitor ESR1 Mutations from Liquid Biopsies

Friday, November 14, 2025

9:15 AM - 10:15 AM EST

Speaker(s)

Deepa Eveleigh, MS (she/her/hers)

Director, Production
Asuragen, a Bio-Techne company
Austin, Texas, United States